Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Pau Montesinos, Andrew H. Wei, Justin M. Watts, Pierre Fenaux et al.
Citations
6 citations
Journal
Journal of Hematology & Oncology
Topics
Acute Myeloid Leukemia Research
Field-Weighted Citation Impact (FWCI)
10.62
article
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Pau Montesinos, Andrew H. Wei, Justin M. Watts, Pierre Fenaux, Stéphane de Botton, Hua Tian, Aaron Sheppard, Eunice S. Wang, David Taussig, Christophe Marzac, Karen W L Yee, Brian A. Jonas, Antonio Curti, Christian Récher, Jorge Alberto Cortés, Jürgen Krauter
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Hematology & OncologyVol. 18(1)
Institutions
Roswell Park Comprehensive Cancer Center (US), The Royal Melbourne Hospital (AU), University of Miami (US), Inserm (FR), Walter and Eliza Hall Institute of Medical Research (AU), Université Paris Cité (FR), Augusta University (US), Université Paris-Saclay (FR), Peter MacCallum Cancer Centre (AU), Institut Gustave Roussy (FR), Princess Margaret Cancer Centre (CA), Hospital Universitari i Politècnic La Fe (ES), Centre Hospitalier Universitaire de Toulouse (FR), Augusta University Health (US), Institut universitaire du cancer de Toulouse Oncopole (FR), Klinikum Braunschweig (DE), Azienda USL di Bologna (IT), Royal Marsden Hospital (GB), National Cancer Center of Georgia (GE), Hôpital Saint-Louis (FR), Sylvester Comprehensive Cancer Center (US), Rigel (United States) (US), Sunesis (United States) (US), University of California, Davis (US)